Skip to main content
. 2010 Sep 7;103(7):987–992. doi: 10.1038/sj.bjc.6605867

Figure 2.

Figure 2

Mean plasma concentration–time profile of JNJ-26483327 after administration of JNJ-26483327 orally BID, days 1 and 28.